# Tumor-to-Tumor Metastasis in a Patient With Hemangioblastoma Unrelated to von Hippel-Lindau Disease: A Case Report and Review of the Literature

**Authors:** Kyoichi Tomoto, Kentaro Watanabe, Takahiro Ogawa, Hisao Sano, Hiroki Suetsugu, Ryoto Wachi, Michihiro Tanaka, Yuichi Murayama, Toshihide Tanaka

PMC · DOI: 10.7759/cureus.86881 · Cureus · 2025-06-27

## TL;DR

A rare case of tumor-to-tumor metastasis involving breast cancer in a hemangioblastoma unrelated to von Hippel-Lindau disease is reported.

## Contribution

This is the first reported case of TTM involving metastatic breast cancer to a sporadic hemangioblastoma unrelated to VHL.

## Key findings

- A 61-year-old woman had TTM with metastatic breast cancer in a hemangioblastoma.
- No evidence of von Hippel-Lindau disease was found in the patient.
- The case emphasizes the need to consider TTM in CNS tumor differential diagnoses.

## Abstract

Tumor-to-tumor metastasis (TTM) is a rare phenomenon in which one malignant tumor ("donor") metastasizes to another benign tumor ("recipient"). In the central nervous system (CNS), meningioma is considered one of the most frequent recipients, while hemangioblastoma (HGB) has also been reported, typically in association with von Hippel-Lindau (VHL) disease.

A 61-year-old woman with a history of bilateral breast cancer treated 17 years earlier presented with right-sided ataxic hemiparesis. Magnetic resonance imaging revealed a gadolinium-enhanced mass in the right cerebellum, initially diagnosed as a metastatic brain tumor. Despite stereotactic radiotherapy, symptoms persisted and the lesion enlarged. Surgical resection was performed via the occipital trans-tentorial approach. Intraoperative findings revealed a reddish, vascular tumor with a xanthochromic area. Complete resection was achieved. Pathological examination confirmed two distinct components: HGB and metastatic breast carcinoma, establishing the diagnosis of TTM. No evidence of VHL was identified. The pathogenesis of TTM remains unclear, although factors such as recipient tumor vascularity and a favorable microenvironment are proposed. The rarity of non-VHL-associated TTM in HGB emphasizes the need for further case accumulation, to clarify the underlying mechanisms.

We report the first description of TTM involving metastatic breast cancer to a sporadic HGB in the CNS, unrelated to VHL. This case highlights the importance of considering TTM among the differential diagnoses for CNS tumors, even in the absence of VHL.

## Linked entities

- **Diseases:** von Hippel-Lindau disease (MONDO:0008667), breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** ataxic hemiparesis (MESH:D010291), meningioma (MESH:D008579), Tumor (MESH:D009369), breast cancer (MESH:D001943), von Hippel-Lindau (VHL) disease (MESH:D006623), Tumor Metastasis (MESH:D009362), CNS tumors (MESH:D016543), brain tumor (MESH:D001932), HGB (MESH:D018325)
- **Chemicals:** gadolinium (MESH:D005682)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12302302/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12302302/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12302302/full.md

---
Source: https://tomesphere.com/paper/PMC12302302